4.7 Article

Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease

Journal

NEUROBIOLOGY OF DISEASE
Volume 102, Issue -, Pages 113-124

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2017.03.002

Keywords

Adult neurogenesis; Neurodl; Mitochondria; Dentate gyrus; Alzheimer's disease

Categories

Funding

  1. Fondation pour la Recherche sur le Cerveau [FRC2008]
  2. JPco-fuND program [MADGIC2016]
  3. Association France Alzheimer [SM2015]
  4. CNRS
  5. Toulouse University
  6. French Ministry for Research
  7. Gueules cassees sourire quand meme
  8. Ministry of Research, Technology and Higher Education Republic of Indonesia
  9. Chile CONACYF

Ask authors/readers for more resources

Adult hippocampal neurogenesis is strongly impaired in Alzheimer's disease (AD). In several mouse models of AD, it was shown that adult -born neurons exhibit reduced survival and altered synaptic integration due to a severe lack of dendritic spines. In the present work, using the APPxPS1 mouse model of AD, we reveal that this reduced number of spines is concomitant of a marked deficit in their neuronal mitochondrial content. Remarkably, we show that targeting the overexpression of the pro -neural transcription factor Neurodl into APPxPS1 adult -born neurons restores not only their dendritic spine density, but also their mitochondrial content and the proportion of spines associated with mitochondria. Using primary neurons, a bona fide model of neuronal maturation, we identified that increases of mitochondrial respiration accompany the stimulating effect of Neurodl overexpression on dendritic growth and spine formation. Reciprocally, pharmacologically impairing mitochondria prevented Neurodl-dependent trophic effects. Thus, since overexpression of Neurodl into new neurons of APPxPS1 mice rescues spatial memory, our present data suggest that manipulating the mitochondrial system of adult -born hippocampal neurons provides neuronal plasticity to the AD brain. These findings open new avenues for far-reaching therapeutic implications towards neurodegenerative diseases associated with cognitive impairment. (C) 2017 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available